Is Teladoc Health Accelerating Growth Through Global Expansion? — Positive
TDOC Zacks Investment Research — November 17, 2025TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.
UBER vs. LYFT: Which Ride-Hailing Stock Is Better Placed Post Q3? — Positive
LYFT UBER Zacks Investment Research — November 17, 2025Lyft's strong gross bookings, the new Curb partnership and a more appealing valuation place it ahead of the rival in the post-third-quarter showdown.
Gap Q3 Earnings Coming Up: What's in Store for the Stock? — Positive
GAP Zacks Investment Research — November 17, 2025GAP's Q3 performance is likely to have benefited from brand momentum and strong back-to-school trends, but rising tariff pressures might have eroded gains.
This Tech Stock Gets a Boost Thanks to a New Bet by Buffett's Berkshire Hathaway — Positive
GOOG GOOGL Investopedia — November 17, 2025Shares of Google parent Alphabet (GOOG, GOOGL) surged Monday after Warren Buffett's Berkshire Hathaway (BRK.A, BRK.B) revealed a new stake in the tech giant.
Transaction in Own Shares 17 November, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 17 November, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 17/11/2025 729,300 28.6600 28.4850 28.5775 LSE GBP 17/11/2025 - - - - Chi-X (CXE) GBP 17/11/2025 - - - - BATS (BXE) GBP 17/11/2025 722,430 32.6700 32.4550 …
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare — Neutral
MOH Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Molina to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Molina Healthcare, Inc. ("Molina" …
MSC Income Fund: A Baby Main Street Capital With Big Income Potential — Positive
MAIN Seeking Alpha — November 17, 2025MSC Income Fund, Inc. offers an attractive blend of high income and undervaluation, trading at a 15–16% discount to NAV. MSIF's dividend yield approaches 11%, with dividends well covered by net investment income and low nonaccruals, supporting income reliability. The portfolio is focused on private, sponsor-backed loans, maintaining conservative leverage and benefiting from lower expenses and insider confidence.
Nvidia shares fall ahead of earnings on Wednesday — Negative
NVDA Bloomberg Markets and Finance — November 17, 2025On this episode of Stock Movers with Lisa Mateo: - Shares of Nvidia (NVDA) edged lower in early trading ahead of the company's highly anticipated earnings report due Wednesday after the close. Monday's premarket dip comes after Peter Thiel's hedge fund Thiel Macro LLC sold off its holdings in Nvidia Corp. during the third quarter, marking another retreat from the leading provider of artificial-intelligence chips.
2 Emerging Tech Stocks for Growth-Minded Investors — Neutral
DDOG SNOW 24/7 Wall Street — November 17, 2025It's fine to stay heavily invested in some of the mega-cap tech titans that are now quite well represented at the top of popular indices such as the Nasdaq 100 or even the S&P 500.
Jacobs Gears Up to Report Q4 Earnings: Key Factors to Note — Positive
J Zacks Investment Research — November 17, 2025J's Q4 results are likely to reflect gains from record backlog and strong demand across key sectors.
Will Coinbase Business' Debut in Singapore Drive Global Expansion? — Neutral
COIN Zacks Investment Research — November 17, 2025Coinbase's Singapore debut for its new Business platform deepens its global push as it scales digital-asset services across Asia.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group — Neutral
MRX Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered in Marex to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Marex Group plc ("Marex" or …
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie — Neutral
JHX Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In James Hardie To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in James Hardie between May 20, 2025 and August 18, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie …
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International — Neutral
BAX Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" …
Atlassian: The Teamwork Engine That's Growing Fast And Profitable — Positive
TEAM Seeking Alpha — November 17, 2025Atlassian's strong product ecosystem and recurring revenue model support long-term growth and customer retention. The company's ongoing investments in cloud migration and innovation drive competitive advantage and expansion opportunities. Valuation remains elevated, but TEAM's robust fundamentals and market leadership justify a positive long-term outlook.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor — Neutral
AVTR Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. ("Avantor" or the …
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of KBR — Neutral
KBR Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In KBR To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in KBR between May 6, 2025 and June 19, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. ("KBR" or …
Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking — Positive
ALGN EPAM MRVL MarketBeat — November 17, 2025The Magnificent Seven—the tech-focused firms among the largest and most influential companies in the world—absolutely dominate the broader market, accounting for a full one-third of the S&P 500. The Roundhill Magnificent Seven ETF BATS: MAGS provides equal-weight exposure to these seven stocks and has returned nearly 20% year-to-date (YTD).
Will Monster Beverage's Expansion Strategy & Energy Drinks Unit Aid? — Positive
MNST Zacks Investment Research — November 17, 2025MNST rides global energy-drink momentum and innovation strength to fuel growth across key markets and its core portfolio.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma — Neutral
ATYR Newsfile Corp — November 17, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 17, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against aTyr Pharma, Inc. ("aTyr" …